news Editing CHO cells with CRISPR-Cas9 improves cell growth and reduces by-products 11 November 2020 | By Victoria Rees (Drug Target Review) Researchers have found bioengineering CHO cells using CRISPR-Cas9 can decrease the secretion of metabolic by-products that hinder growth.
article Five recent Parkinson’s disease drug target discoveries 10 September 2019 | By Victoria Rees (Drug Target Review) This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
news New body of resistance gene research has potential to combat superbugs 8 February 2018 | By Drug Target Review Scientists in Denmark have made it possible to rank the risk of resistance genes and predict the evolution of existing and future drugs.
article Deadly bite: How Venomab’s novel research is tackling the global antivenom shortage 21 March 2017 | By Niamh Marriott (Drug Target Review) We caught up with Andreas Laustsen Co-Founder and CEO of Venomab, to find the latest in antivenom research…